Roundup Lawsuit Settlement Amounts — April 2026 Update

Roundup Settlement Status — April 2026

The Roundup litigation is one of the largest mass torts in US history. Here is the current state of settlements and ongoing litigation:

Total Settlements to Date

Bayer has paid approximately $11 billion to settle Roundup cases
Around 100,000 cases have been resolved
Bayer set aside additional funds for future claims
New cases continue to be filed by recently diagnosed plaintiffs

Estimated Settlement Ranges

Based on resolved cases and current settlement programs:

Case Strength	Estimated Range	Typical Profile
Tier 1 (Very Strong)	$250,000 — $500,000+	Heavy occupational exposure, clear NHL diagnosis, no alternative causes
Tier 2 (Strong)	$100,000 — $250,000	Significant exposure, clear diagnosis, good medical records
Tier 3 (Moderate)	$40,000 — $150,000	Moderate exposure, NHL diagnosis, some causation challenges
Tier 4 (Mild)	$5,000 — $40,000	Limited exposure, less severe cancer, more challenging cases

Average settlement values for Roundup cases have been estimated around $100,000 to $175,000 per plaintiff, though individual cases vary widely.

Notable Roundup Verdicts

Case	Year	Initial Verdict	Final Amount
Johnson v. Monsanto	2018	$289 million	$20.5 million (after reductions)
Hardeman v. Monsanto	2019	$80 million	$25 million (after appeals)
Pilliod v. Monsanto	2019	$2.05 billion	$86.7 million (after reductions)
Various 2020-2023	Mixed	Various	Mixed outcomes

These verdicts illustrate that juries take Roundup cases seriously, though many awards are reduced on appeal.

Factors That Affect Individual Settlement Value

Severity and stage of cancer — Advanced stages typically have higher value
Type of NHL — Some subtypes have stronger evidentiary support
Duration and intensity of exposure — Heavy occupational exposure strengthens cases
Documentation of exposure — Employment records, purchase history
Age at diagnosis — Younger plaintiffs may have higher lifetime damages
Medical expenses — Total past and projected costs
Treatment response — Cases involving recurrence or terminal diagnoses
Strength of causation — Lack of family history, other risk factors

Bayer's Settlement Approach

Bayer has used several approaches to resolve Roundup cases:

Inventory settlements — Resolving large groups of similar cases at once
Individual settlements — Negotiating with specific plaintiffs
Trial defense — Continuing to defend select cases at trial
Future claims funds — Reserving money for cases not yet filed

Why New Cases Are Still Being Filed

Despite over $11 billion in settlements, new Roundup cases continue because:

NHL has long latency — People exposed years ago are still being diagnosed
Statute of limitations runs from diagnosis, not exposure
Bayer continues to sell Roundup in the US
Settlement programs remain active for qualifying claimants
New medical evidence continues to emerge

Expected Timeline for New Cases

Case filing: Can be done immediately after qualifying diagnosis
Initial review: 30-90 days to gather records and assess case
Settlement evaluation: 6-18 months for many cases
Resolution: Typically 1-3 years for settled cases

What You Should Do Now

Don't wait — Statutes of limitations are running
Gather medical records — All NHL diagnosis and treatment records
Document exposure — Employment, purchase records, photos, witness statements
Talk to a lawyer — Attorneys are still actively reviewing Roundup cases
Consider all possible exposure — Occupational and residential use both count